Editor's Note :

Editor's Note :

In previous years, the Court released orders the morning after the Court’s “Long Conference.” It has not done so this year. Beginning last Term, the Court consistently considered petitions at least two times before granting certiorari. To the extent that practice continues -- and there is no affirmative evidence the Court intends to drop it -- so we are again doubtful that certiorari will be granted in any cases today.

Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc.

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term
13-1251 Fed. Cir. TBD TBD TBD TBD TBD

Issue: Whether the statutory bar for “public use” of an invention under 35 U.S.C. § 102(b) (2006) (pre-America Invents Act) (current version at 35 U.S.C. § 102(a)(1)(2012)) broadly bars a patent when an innovator company allows any public access to its invention even if the invention is not actually used in public for its intended purpose.

SCOTUSblog Coverage

DateProceedings and Orders
Apr 16 2014Petition for a writ of certiorari filed. (Response due May 19, 2014)
May 15 2014Order extending time to file response to petition to and including June 18, 2014, for all respondents.
Jun 18 2014Brief of respondent Teva Pharmaceuticals USA, Inc., et al. in opposition filed.
Jul 2 2014DISTRIBUTED for Conference of September 29, 2014.
 
Share:
Term Snapshot
Awards